BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 25728920)

  • 21. Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models.
    Nurden AT; Fiore M; Nurden P; Pillois X
    Blood; 2011 Dec; 118(23):5996-6005. PubMed ID: 21917754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of one novel pathogenic
    Lu Z; Nikuze L; Zhong Z; Li F; Zhang F; Liang K; Wei M; Wei H
    Platelets; 2020; 31(3):355-359. PubMed ID: 31088191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. αIIbβ3 variants defined by next-generation sequencing: predicting variants likely to cause Glanzmann thrombasthenia.
    Buitrago L; Rendon A; Liang Y; Simeoni I; Negri A; ; Filizola M; Ouwehand WH; Coller BS
    Proc Natl Acad Sci U S A; 2015 Apr; 112(15):E1898-907. PubMed ID: 25827233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New αIIbβ3 variants in 28 Turkish Glanzmann patients; structural hypothesis for complex activation by residues variations in I-EGF domains.
    Koker MY; Sarper N; Albayrak C; Zulfikar B; Zengin E; Saraymen B; Albayrak D; Koc B; Avcilar H; Karakükcü M; Chenet C; Bianchi F; de Brevern AG; Petermann R; Jallu V
    Platelets; 2022 May; 33(4):551-561. PubMed ID: 34275420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel amino acid substitution of integrin αIIb in Glanzmann thrombasthenia confirms that the N-terminal region of the receptor plays a role in maintaining β-propeller structure.
    Pillois X; Fiore M; Heilig R; Pico M; Nurden AT
    Platelets; 2013; 24(1):77-80. PubMed ID: 22394243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunisation against αIIbβ3 and αvβ3 in a type 1 variant of Glanzmann's thrombasthenia caused by a missense mutation Gly540Asp on β3.
    Wihadmadyatami H; Röder L; Berghöfer H; Bein G; Heidinger K; Sachs UJ; Santoso S
    Thromb Haemost; 2016 Aug; 116(2):262-71. PubMed ID: 27098940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of compound heterozygous mutations in the ITGA2B gene in a Chinese patient with Glanzmann thrombasthenia.
    Zheng JY; Jin YH; Zhu YL; Jin PP; Zhang DT; Jin ZB
    Chin Med J (Engl); 2010 Jun; 123(11):1397-401. PubMed ID: 20819594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel 196Leu to Pro substitution in the beta3 subunit of the alphaIIbbeta3 integrin in a patient with a variant form of Glanzmann thrombasthenia.
    Nurden AT; Ruan J; Pasquet JM; Gauthier B; Combrié R; Kunicki T; Nurden P
    Platelets; 2002 Mar; 13(2):101-11. PubMed ID: 11897046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Novel Frameshift Mutation in the ITGB3 Gene Leading to Glanzmann's Thrombasthenia in a Saudi Arabian Family.
    Alharbi A; Hashmi JA; Alharby E; Albalawi AM; Ramzan K; Basit S
    Hematol Oncol Stem Cell Ther; 2022 Mar; 15(1):21-26. PubMed ID: 33600779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel homozygous mutation (c.175delG) in platelet glycoprotein ITGA2B gene as cause of Glanzmann's thrombasthenia type I.
    Vannier C; Behnisch W; Bartsch I; Sandrock K; Ertle F; Schmidt K; Busse A; Superti-Furga A; Kulozik A; Santoso S; Zieger B
    Klin Padiatr; 2010 May; 222(3):150-3. PubMed ID: 20514618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular dynamics analysis of a novel β3 Pro189Ser mutation in a patient with glanzmann thrombasthenia differentially affecting αIIbβ3 and αvβ3 expression.
    Laguerre M; Sabi E; Daly M; Stockley J; Nurden P; Pillois X; Nurden AT
    PLoS One; 2013; 8(11):e78683. PubMed ID: 24236036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type I Glanzmann thrombasthenia caused by an apparently silent beta3 mutation that results in aberrant splicing and reduced beta3 mRNA.
    Xie J; Pabón D; Jayo A; Butta N; González-Manchón C
    Thromb Haemost; 2005 May; 93(5):897-903. PubMed ID: 15886806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SINE-VNTR-Alu retrotransposon insertion as a novel mutational event underlying Glanzmann thrombasthenia.
    Zhang J; Tang J; Li G; Li N; Wang J; Yao R; Yu T
    J Thromb Haemost; 2023 Dec; 21(12):3597-3607. PubMed ID: 37604334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disulfide bond disruption by a beta 3-Cys549Arg mutation in six Jordanian families with Glanzmann thrombasthenia causes diminished production of constitutively active alpha IIb beta 3.
    Mor-Cohen R; Rosenberg N; Peretz H; Landau M; Coller BS; Awidi A; Seligsohn U
    Thromb Haemost; 2007 Dec; 98(6):1257-65. PubMed ID: 18064323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A beta3 Asp217-->Val substitution in a patient with variant Glanzmann Thrombasthenia severely affects integrin alphaIIBbeta3 functions.
    D'Andrea G; Bafunno V; Del Vecchio L; Amoriello A; Morabito P; Vecchione G; Grandone E; Margaglione M
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):657-62. PubMed ID: 18832906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations of the platelet proteome in type I Glanzmann thrombasthenia caused by different homozygous delG frameshift mutations in ITGA2B.
    Loroch S; Trabold K; Gambaryan S; Reiß C; Schwierczek K; Fleming I; Sickmann A; Behnisch W; Zieger B; Zahedi RP; Walter U; Jurk K
    Thromb Haemost; 2017 Feb; 117(3):556-569. PubMed ID: 28078347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel Pro126His beta propeller mutation in integrin alphaIIb causes Glanzmann thrombasthenia by impairing progression of pro-alphaIIbbeta3 from endoplasmic reticulum to Golgi.
    Shen WZ; Ding QL; Jin PP; Wang XF; Jiang YZ; Li SM; Wang HL
    Blood Cells Mol Dis; 2009; 42(1):44-50. PubMed ID: 18976939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diversity of Glanzmann thrombasthenia in southern India: 10 novel mutations identified among 15 unrelated patients.
    Nelson EJ; Nair SC; Peretz H; Coller BS; Seligsohn U; Chandy M; Srivastava A
    J Thromb Haemost; 2006 Aug; 4(8):1730-7. PubMed ID: 16879215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glanzmann thrombasthenia: state of the art and future directions.
    Nurden AT; Pillois X; Wilcox DA
    Semin Thromb Hemost; 2013 Sep; 39(6):642-55. PubMed ID: 23929305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations in the beta3 gene giving rise to type I Glanzmann thrombasthenia in two families in Portugal.
    Garcia LC; Breillat C; Lima M; Combrié R; Morais S; Teixera Mdos A; Campos M; Justica B; Nurden AT
    Platelets; 2004 Feb; 15(1):15-22. PubMed ID: 14985172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.